← Back to headlines
Johnson & Johnson's Q1 Profit Exceeds Estimates Despite Stelara Sales Disappointment
Johnson & Johnson reported first-quarter profits that surpassed analyst estimates, even as sales of its key drug Stelara fell short of expectations.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
Related Stories
Toxic Smoke from Navotas Landfill Fire Reaches Bulacan Villages
just now
Financial Barriers Hinder Vaccine Access in Philippines
just now
Polish Employers Consider Time Off for Preventive Health Check-ups
14m ago
German Health Minister's Reform Criticized for Impact on Workers and Unaddressed Savings
21m ago